Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines—Lessons Learned From the Global Perspective by Gonzalez, Alejandro Ramirez, Farrell, Margaret, Menning, Lisa, Garon, Julie, Everts, Hans, Hampton, Lee M., Dolan, Samantha B., Shendale, Stephanie, Wanyoike, Sarah, Veira, Chantal Laroche, du Châtellier, Gaël Maufras, Kurji, Feyrouz, Rubin, Jennifer, Boualam, Liliane, Blanc, Diana Chang, Patel, Manish

Get full text

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency by Kurji, Feyrouz Damji, Bandyopadhyay, Ananda Sankar, Zipursky, Simona, Cooper, Laura V, Gast, Chris, Toher, Margaret, Clemens, Ralf, Clemens, Sue Ann Costa, Prasad, Rayasam, Azhari, Adriansjah

Get full text

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience by Macklin, Grace R., Peak, Corey, Eisenhawer, Martin, Kurji, Feyrouz, Mach, Ondrej, Konz, John, Gast, Chris, Bachtiar, Novilia Sjafri, Bandyopadhyay, Ananda S., Zipursky, Simona

Get full text

Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame by Zipursky, Simona, Patel, Manish, Farrell, Margaret, Gonzalez, Alejandro Ramirez, Kachra, Tasleem, Folly, Yann, Kurji, Feyrouz, Veira, Chantal Laroche, Wootton, Emily, Hampton, Lee M.

Get full text

Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine—Lessons Learned by Shendale, Stephanie, Farrell, Margaret, Hampton, Lee M., Harris, Jennifer B., Kachra, Tasleem, Kurji, Feyrouz, Patel, Manish, Gonzalez, Alejandro Ramirez, Zipursky, Simona

Get full text

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021 by Martin, Javier, Burns, Cara C, Jorba, Jaume, Shulman, Lester M, Macadam, Andrew, Klapsa, Dimitra, Majumdar, Manasi, Bullows, James, Frolov, Ann, Mate, Ryan, Bujaki, Erika, Castro, Christina J, Bullard, Kelley, Konz, John, Hawes, Kaija, Gauld, Jillian, Blake, Isobel M, Mercer, Laina D, Kurji, Feyrouz, Voorman, Arie, Diop, Ousmane M, Oberste, M Steven, Modlin, John, Macklin, Grace, Eisenhawer, Martin, Bandyopadhyay, Ananda S, Zipursky, Simona

Get full text

Genetic characterization of novel oral polio vaccine type 2 viruses during initial use phase under emergency use listing--worldwide, March-October 2021/Caracterisation genetique de... by Martin, Javier, Burns, Cara C, Jorba, Jaume, Shulman, Lester M, Macadam, Andrew, Klapsa, Dimitra, Majumdar, Manasi, Bullows, James, Frolov, Ann, Mate, Ryan, Bujaki, Erika, Castro, Christina J, Bullard, Kelley, Konz, John, Hawes, Kaija, Gauld, Jillian, Blake, Isobel M, Mercer, Laina D, Kurji, Feyrouz, Voorman, Arie, Diop, Ousmane M, Oberste, Steven, Modlin, John, Macklin, Grace, Eisenhawer, Martin, Bandyopadhyay, Ananda S, Zipursky, Simona

Get full text

Genetic characterization of novel oral polio vaccine type 2 viruses during initial use phase under emergency use listing – worldwide, March–October 2021 by Martin, Javier, Burns, Cara C, Jorba, Jaume, Shulman, Lester M, Macadam, Andrew, Klapsa, Dimitra, Majumdar, Manasi, Bullows, James, Frolov, Ann, Mate, Ryan, Bujaki, Erika, Castro, Christina J, Bullard, Kelley, Konz, John, Hawes, Kaija, Gauld, Jillian, Blake, Isobel M, Mercer, Laina D, Kurji, Feyrouz, Voorman, Arie, Diop, Ousmane M, Oberste, Steven, Modlin, John, Macklin, Grace, Eisenhawer, Martin, Bandyopadhyay, Ananda S, Zipursky, Simona

Get full text